Literature DB >> 17948610

Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720.

Gerold Bepler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948610     DOI: 10.3816/CLC.2007.n.039

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  ERCC1 Expression Analysis to Guide Therapy in Non-Small Cell Lung Cancer.

Authors:  Diane Allingham-Hawkins; Andrew Lea; Susan Levine
Journal:  PLoS Curr       Date:  2010-12-06

2.  [Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012].

Authors:  David R Gandara; Philip C Mack; Tianhong Li; Primo N Lara; Roy S Herbst
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.